Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the efficacy and safety of Ostenil application (1% hyaluronan) after arthroscopy of the wrist.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Orthopädische Gemeinschaftspraxis
Straubing, Bavaria, Germany
Start Date
January 1, 2007
Primary Completion Date
August 1, 2009
Completion Date
August 1, 2009
Last Updated
September 28, 2011
140
ACTUAL participants
Ostenil
DEVICE
Standard arthroscopic procedure
PROCEDURE
Lead Sponsor
TRB Chemedica AG
NCT07468045
NCT07046390
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04726280